Case Details
Unifying Scientific Voice

Unifying Scientific Voice

Client Challenge

A biotech company preparing for its first commercial launch had a promising biologic for a rare autoimmune condition. But internally, teams were speaking different scientific languages. Field training, global affiliate messaging, and agency deliverables all felt disjointed. The brand needed a unifying thread to bring clarity across the board.

What We Did

Stotalis stepped in to build the brand’s scientific foundation from the inside out. We started by conducting stakeholder interviews across medical, regulatory, and commercial teams to surface gaps and inconsistencies. Then, we created a full scientific platform that distilled complex immunopathology into a cohesive, flexible narrative.

This included:

A refined scientific lexicon used across affiliates
Core disease and treatment narratives grounded in the latest evidence
Visual metaphors that humanized the patient experience

We followed up with alignment workshops to embed this framework into day-to-day strategy and execution.

The Impact

Post-workshop surveys showed full team alignment on the brand's core scientific story
MLR approval timelines for launch materials improved significantly
Global teams adopted the lexicon and platform as the gold standard

Why It Matters

Every great launch begins with a story that holds up to scrutiny. When internal teams speak the same scientific language, everything from medical booth conversations to field engagements becomes sharper and more consistent. We helped this brand show up with purpose, direction, and confidence from day one.

Project Information
Scientific Clarity for a Rare Disease Launch
Scientific Strategy
Strategy, Launch, Alignment
3.5 months
Let’s work together
Let’s work together

Call Us Now

404-912-9060
Cart (0 items)